Physician profile
Arthur E Orlick
NPI 1639143456
$611.86
in general payments reported to CMS, 2019-2025
12 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $46.46 · 2021: $266 · 2022: $190 · 2023: $110.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $110.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $109.62 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kestra Medical Technology Services, INC. | $157.91 | 2022 | |
| Edwards Lifesciences Corporation | $127.44 | 2021 | |
| Irhythm Technologies, INC. | $78.78 | 2020-2021 | |
| Boston Scientific Corporation | $63.69 | 2021-2023 | Watchman Access System |
| Boehringer Ingelheim Pharmaceuticals, INC. | $40.04 | 2023 | Jardiance |
| Merck Sharp & Dohme LLC | $32.08 | 2021-2022 | |
| Abbott Laboratories | $24.27 | 2023 | Amplatzer Amulet |
| Amgen INC. | $23.94 | 2023 | Repatha |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $18.49 | 2020 | |
| Janssen Pharmaceuticals, INC | $15.97 | 2022 | |
| E.R. Squibb & Sons, L.L.C. | $15.34 | 2021 | |
| Esperion Therapeutics, INC. | $13.91 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Arthur Orlick listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.